SCHEMBL13301595

SCHEMBL13301595

c1ccc(N(c2ccc3c(c2)c2ccccc2n3-c2ccc(-n3c4ccccc4c4ccccc43)cc2)c2ccc3c(c2)c2ccccc2n3-c2ccc(-n3c4ccccc4c4ccccc43)cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.55
L3MBTL1 Q9Y468 2/20 0.55
ATM Q13315 1/20 0.55
ALDH1A1 P00352 4/20 0.37
MAPT P10636 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
PTPN1 P18031 2/20 0.36
MAPK8 P45983 1/20 0.36
HDAC4 P56524 1/20 0.35
HPGD P15428 3/20 0.35
HSD17B10 Q99714 2/20 0.35
HTT P42858 2/20 0.35
MEN1 O00255 1/20 0.35
MAPK1 P28482 1/20 0.35
HBB P68871 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13301592 1.00 KDM4E (0.55) KDM4EL3MBTL1ATMALDH1A1MAPT
SCHEMBL4661898 1.00 KDM4E (0.55) KDM4EL3MBTL1ATMALDH1A1MAPT
SCHEMBL76544 1.00 KDM4E (0.55) KDM4EL3MBTL1ATMALDH1A1MAPT
SCHEMBL76676 1.00 KDM4E (0.55) KDM4EL3MBTL1ATMALDH1A1MAPT
SCHEMBL18775509 0.98 KDM4E (0.58) KDM4EL3MBTL1ATMALDH1A1MAPT
SCHEMBL13301597 0.98 KDM4E (0.58) KDM4EL3MBTL1ATMALDH1A1MAPT
SCHEMBL23352493 0.97 KDM4E (0.60) KDM4EL3MBTL1ATMALDH1A1MAPT
SCHEMBL13301599 0.97 KDM4E (0.60) KDM4EL3MBTL1ATMALDH1A1MAPT
SCHEMBL14032826 0.97 KDM4E (0.60) KDM4EL3MBTL1ATMALDH1A1MAPT
SCHEMBL12856899 0.97 KDM4E (0.60) KDM4EL3MBTL1ATMALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100145067-A1 NOVEL CARBAZOLES DERIVATIVE AND USE THEREOF BANDO CHEMICAL INDUSTRIES, LTD. (JP) 2010-06-10 US disclosed
US-20100145067-A1 NOVEL CARBAZOLES DERIVATIVE AND USE THEREOF BANDO CHEMICAL INDUSTRIES, LTD. (JP) 2010-06-10 US disclosed
EP-2100880-A1 NOVEL CARBAZOLE DERIVATIVE AND USE THEREOF Bando Chemical Industries, Ltd. (JP) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100145067-A1 NOVEL CARBAZOLES DERIVATIVE AND USE THEREOF GDI2, SGK2, GDI1 KDM4E 1016/4885L3MBTL1 3298/4885ATM 1735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.